Full-Time

Medical Affairs Manager Advanced Access Devices

Aad, Hybrid

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

No salary listed

Senior, Expert

Salt Lake City, UT, USA + 1 more

More locations: Midland Park, NJ, USA

Candidate must be on-site a minimum of 4 days per week.

Category
Healthcare Administration & Support
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Risk Management
Requirements
  • RN, NP/PA, CRNA or MD required
  • Minimum 5 years of experience in clinical practice preferred
  • Minimum 2 years related experience in the medical device or pharmaceutical industry within Medical Affairs is preferred
  • Proven business acumen and critical thinking skills
  • Ability to identify unmet clinical needs, evaluate product opportunities from a clinical perspective and help develop strategies that lead to efficient development of new opportunities
  • Process-oriented and demonstrates a sense of urgency in completing deliverables through effective goal setting and a strong result orientation
  • Able to organize, prioritize and work effectively in a constantly evolving and matrixed environment
  • Excellent scientific and medical written/verbal communication and presentation skills along with strong computer software skills
  • Knowledgeable in the areas of clinical, commercial, and regulatory issues affecting the medical device industry
  • Ability and to travel as needed ~25%
Responsibilities
  • Participates in Medical Affairs maintenance of business activities, new product innovation and customer/KOL engagement
  • Supports the management of Quality and Risk documents as a medical expert
  • Supports AAD MA Team collaboration functionally in creating and implementing strategic go-to-market approaches
  • Contributes to the development and implementation of internal and external scientific and medical educational programs
  • Contributes to the development and implementation of clinical research and educational projects in key areas of interest
  • Participates in HRA development and in crisis-management teams for marketed products, i.e., in case of field corrective actions
  • Ensures relevant responses to customer inquiries concerning BD products
  • Conducts regular review of scientific literature in collaboration with marketing for key-products
  • Continuously maintains SME knowledge concerning developments and trends in medical science relevant to the business
  • Participate in the distribution of scientific and medical information to internal and external customers while meeting appropriate legal and regulatory guidelines
  • Continuously develops knowledge of regulatory, pharmacovigilance, and quality assurance requirements in alignment with Company Practice Standards
Desired Qualifications
  • Master’s degree in a health field preferred
  • Working knowledge of safety reporting requirements for devices preferred

BD (Becton, Dickinson and Company) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on medication management and delivery; BD Life Sciences, which provides products for safe collection and transport of diagnostic specimens; and BD Interventional, which offers devices for minimally invasive surgeries. The company generates revenue by selling medical devices, laboratory equipment, and diagnostic products. BD stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and enhancing safety and efficiency in healthcare.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...